Biomedical Politics.

Mostrar otras versiones (1)
Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor principal: Staff, Institute of Medicine
Otros Autores: Hanna, Kathi E.
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Washington : National Academies Press, 1991.
Colección:Online access: National Academy of Sciences National Academies Press.
Online access: NCBI NCBI Bookshelf.
Temas:
Medical policy > Case studies.
Health planning > Case studies.
Politique sanitaire > Études de cas.
Santé publique > Planification > Études de cas.
Health planning
Medical policy
Case studies
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000Mu 4500
001 EBOOKCENTRAL_ocn923263800
003 OCoLC
005 20240329122006.0
006 m o d
007 cr |n|||||||||
008 151010s1991 dcu o 000 0 eng d
040 |a EBLCP  |b eng  |e pn  |c EBLCP  |d OCLCQ  |d MERUC  |d OCLCQ  |d ZCU  |d ICG  |d OCLCO  |d OCLCF  |d OCLCQ  |d OCLCO  |d OCLCQ  |d LVT  |d DKC  |d OCLCQ  |d UKAHL  |d OCLCQ  |d OCLCO  |d OCLCQ  |d OCLCO  |d OCLCL 
019 |a 1229382924 
020 |a 9780309597579 
020 |a 0309597579 
020 0 |a 9780309044868 
020 |a 0309044863 
029 1 |a DEBBG  |b BV044107144 
035 |a (OCoLC)923263800  |z (OCoLC)1229382924 
050 4 |a RA393.B48 1991eb 
082 0 4 |a 610.28 
049 |a UAMI 
100 1 |a Staff, Institute of Medicine. 
245 1 0 |a Biomedical Politics. 
260 |a Washington :  |b National Academies Press,  |c 1991. 
300 |a 1 online resource (360 pages) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
588 0 |a Print version record. 
505 0 |a Biomedical Politics -- Copyright -- Preface -- Acknowledgments -- Contents -- Introduction -- References -- Unproven AIDS Therapies: The Food and Drug Administration and DDI -- THE DRUG REGULATION PROCESS -- The Drug Approval Process Today -- Speeding Up the Process: The Bush Initiative -- Prelicensing Availability -- PARALLEL TRACK -- PARALLEL TRACK: PROS AND CONS -- The Food and Drug Administration -- The Research Community -- The AIDS Activists -- Other Consumer Interests -- EARLY RELEASE OF DDI -- MOTIVATIONS -- Bristol-Myers 
505 8 |a The Food and Drug AdministrationThe National Institutes of Health -- The Activists -- CONCLUSIONS -- NOTES -- REFERENCES -- Commentary -- LEON EISENBERG -- Commentary -- PETER F. CARPENTER -- A Political History of RU-486 -- Introducing Contraceptives to the United States -- THE EARLY DEVELOPMENT OF RU-486 -- COMMERCIAL INTEREST IN RU-486 -- THE GROWING THREAT OF ANTI-ABORTION GROUPS -- CORPORATE PRESSURE FOR WITHDRAWAL -- THE RETURN OF RU-486 -- THE CONTINUING OPPOSITION -- SUCCESS OF THE BOYCOTT THREAT 
505 8 |a THE FEMINIST AND MEDICAL COMMUNITY RESPONSEINTERNATIONAL RU-486 AVAILABILITY -- GETTING RU-486 TO THE UNITED STATES -- INDUSTRY CONSTRAINTS ON RU-486 DEVELOPMENT -- Market Share and Price -- FDA Review -- Product Liability -- Public Relations -- AMERICAN ACCESS TO RU-486 IN THE 1990S -- REFERENCES -- Commentary -- WILLIAM N. HUBBARD -- Commentary -- PETER F. CARPENTER -- The Human Genome Project: The Formation of Federal Policies in the United States, 1986â€?1990 -- TECHNICAL AND SCIENTIFIC BACKGROUND -- ORIGINS OF DEDICATED GENOME RESEARCH PROGRAMS 
505 8 |a THE DEPARTMENT OF ENERGY PLANTHE SCIENTIFIC COMMUNITY RESPONDS -- CALLS FOR EVALUATION -- THE NATIONAL INSTITUTES OF HEALTH AND CONGRESS RESPOND -- THE PROJECT IS FUNDED -- SOCIAL ISSUES EMERGE -- STILL, ORGANIZATIONAL ISSUES -- CONCLUSIONS -- APPENDIX A -- Where Was OSTP? -- APPENDIX B -- Can the Genome Project Keep Its Promises? -- APPENDIX C -- Is Cost Wobble a Serious Problem? -- APPENDIX D -- What Is Technically Feasible in the Policy Context? -- REFERENCES -- Commentary -- PAUL BERG -- Commentary -- ERNEST R. MAY 
505 8 |a Origins of the Medicare Kidney Disease Entitlement: The Social Security Amendments of 1972A HISTORICAL FOOTNOTE -- ANTECEDENTS TO THE 1972 LEGISLATION -- The Influence of the Gottschalk Report -- Setting the Legislative Stage -- THE SOCIAL SECURITY AMENDMENTS OF 1972, SECTION 299I -- The Legislative Process -- The Policy Context -- The Adoption of Section 299I -- Ways and Means: November and December 1971 -- Senate Finance Committee: 1972 -- The Joint House-Senate Conference Committee: 1972 -- ESTIMATES OF COST -- SUMMARY AND CONCLUSIONS -- AFTERWORD 
500 |a ""Appendix"" 
590 |a ProQuest Ebook Central  |b Ebook Central Academic Complete 
650 0 |a Medical policy  |v Case studies. 
650 0 |a Health planning  |v Case studies. 
650 6 |a Politique sanitaire  |v Études de cas. 
650 6 |a Santé publique  |x Planification  |v Études de cas. 
650 7 |a Health planning  |2 fast 
650 7 |a Medical policy  |2 fast 
655 7 |a Case studies  |2 fast 
700 1 |a Hanna, Kathi E. 
758 |i has work:  |a Biomedical politics (Text)  |1 https://id.oclc.org/worldcat/entity/E39PCGVvVGFWfBXTYyrmyF9pWC  |4 https://id.oclc.org/worldcat/ontology/hasWork 
776 0 8 |i Print version:  |a Staff, Institute of Medicine.  |t Biomedical Politics.  |d Washington : National Academies Press, ©1900  |z 9780309044868 
830 0 |a Online access: National Academy of Sciences National Academies Press. 
830 0 |a Online access: NCBI NCBI Bookshelf. 
856 4 0 |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=3376436  |z Texto completo 
938 |a Askews and Holts Library Services  |b ASKH  |n AH36567554 
938 |a EBL - Ebook Library  |b EBLB  |n EBL3376436 
994 |a 92  |b IZTAP 

Ejemplares similares